The Regulatory Climate with Covid-19

Due to COVID-19, many regulatory organisations have had to rapidly adapt current regulations and policies to evolve in the post-COVID-19 world. This webinar will provide examples from different areas of regulatory affairs. We will address policy changes to improve medicine access; supply chain logistics; repurposing and access to medicines; and discuss a case study from Macau; followed by a panel discussion.
Learning objectives:
- to outline different regulatory areas which have been adjusted within the COVID-19 pandemic
- to explain how pharmacists have been involved and implemented these new regulations and changes to their practice
-to identify the roles pharmacists can play in identifying and advocating for improved regulations and policy changes
- to understand the ethical considerations for access to medicines in times of pandemic

Moderator;
Timothy Chen, Professor of Medication Management The University of Sydney - Australia

Facilitator: Tara Hehir, SAPS Secretary

Panellists:
1. Cody Midlam, Consultant Pharmacist Willis Towers Watson - USA
2. Peter Guthrey, Senior Pharmacist – Strategic Policy The Pharmaceutical Society of Australia - Australia
3. Carolina Ung, Macau Fellow (Lecturer) in the Institute of Chinese Medical Sciences University of Macau
4. Betty Chaar, Associate Professor of Professional Ethics in Pharmacy Practice University of Sydney - Australia